These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol. Jick SS, Kaye JA, Russmann S, Jick H. Contraception; 2006 Mar; 73(3):223-8. PubMed ID: 16472560 [Abstract] [Full Text] [Related]
5. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol. Brenner P. Contraception; 2006 Oct; 74(4):354; author reply 354-5. PubMed ID: 16982246 [No Abstract] [Full Text] [Related]
6. Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch. Jick SS, Jick H. Contraception; 2006 Oct; 74(4):290-2. PubMed ID: 16982227 [Abstract] [Full Text] [Related]
12. A clinical study of transdermal contraceptive patch in Thai adolescence women. Piyasirisilp R, Taneepanichskul S. J Med Assoc Thai; 2008 Feb; 91(2):137-41. PubMed ID: 18389975 [Abstract] [Full Text] [Related]